| Low‐fouling fluoropolymers for bioconjugation and in vivo tracking C Fu, B Demir, S Alcantara, V Kumar, F Han, HG Kelly, X Tan, Y Yu, W Xu, ... Angewandte Chemie 132 (12), 4759-4765, 2020 | 70 | 2020 |
| Sustained-release ketamine-loaded nanoparticles fabricated by sequential nanoprecipitation FY Han, Y Liu, V Kumar, W Xu, G Yang, CX Zhao, TM Woodruff, ... International journal of pharmaceutics 581, 119291, 2020 | 44 | 2020 |
| Proteins conjugated with sulfoxide-containing polymers show reduced macrophage cellular uptake and improved pharmacokinetics Y Yu, W Xu, X Huang, X Xu, R Qiao, Y Li, F Han, H Peng, TP Davis, C Fu, ... ACS Macro Letters 9 (6), 799-805, 2020 | 42 | 2020 |
| Use of microfluidics to fabricate bioerodable lipid hybrid nanoparticles containing hydromorphone or ketamine for the relief of intractable pain M Zhu, AK Whittaker, X Jiang, R Tang, X Li, W Xu, C Fu, MT Smith, ... Pharmaceutical Research 37 (10), 211, 2020 | 14 | 2020 |
| Optimisation of a Microfluidic Method for the Delivery of a Small Peptide FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ... Pharmaceutics 13 (9), 1505, 2021 | 6 | 2021 |
| Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ... Advanced Therapeutics 5 (12), 2200109, 2022 | 4 | 2022 |
| Sustained release ketamine-loaded porous silicon-PLGA microparticles prepared by an optimized supercritical CO2 process W Xu, Z Zhao, J Falconer, AK Whittaker, A Popat, MT Smith, T Kumeria, ... Drug Delivery and Translational Research 12 (3), 676-694, 2021 | 4 | 2021 |
| Metabolic aspects of genetic ion channel epilepsies ES Neal, W Xu, K Borges Journal of Neurochemistry, 2023 | 3 | 2023 |
| Low-fouling gold nanorod theranostic agents enabled by a sulfoxide polymer coating Y Chang, Q Wang, W Xu, X Huang, X Xu, FY Han, R Qiao, GR Ediriweera, ... Biomacromolecules 23 (9), 3866-3874, 2022 | 3 | 2022 |
| Alterations in mitochondrial glucose carbon metabolism in epilepsy and targeted metabolic treatments FY Han, T McDonald, W Xu, K Borges Clinical bioenergetics, 653-677, 2021 | 2 | 2021 |
| Glyceryl triacetate feeding in mice increases plasma acetate levels but has no anticonvulsant effects in acute electrical seizure models W Xu, ES Neal, M Plan, K Borges Epilepsy & Behavior 137, 108964, 2022 | 1 | 2022 |
| Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice W Xu, F Maqbool, V Kumar, JR Falconer, CS Cui, TM Woodruff, K Borges, ... Drug Delivery and Translational Research, 1-9, 2021 | 1 | 2021 |
| Case for supporting astrocyte energetics in glucose transporter 1 deficiency syndrome W Xu, K Borges Epilepsia, 2024 | | 2024 |
| Transient anticonvulsant effects of time-restricted feeding in the 6-Hz mouse model OJ Armstrong, ES Neal, D Vidovic, W Xu, K Borges Epilepsy & Behavior 151, 109618, 2024 | | 2024 |
| Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy (Adv … W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ... Advanced Therapeutics 5 (12), 2270030, 2022 | | 2022 |
| Dietary management of canine epilepsy ES Neal, W Xu, K Borges Edra Publsihing, 2022 | | 2022 |
| Optimisation of a Microfluidic Method for the Delivery of a Small Peptide. Pharmaceutics 2021, 13, 1505 FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ... Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis …, 2021 | | 2021 |
